Proof of Usefulness Report

Cytespace Africa Laboratories

Analysis completed on 2/7/2026

+583
Proof of Usefulness Score
Industry Mainstay

The project represents a substantial, real-world entity (Cytespace Africa Laboratories, part of MLM Medical Labs) with verified scale (125+ employees, est. 1999) and critical utility in clinical research and TB testing. However, the submission itself is of very low quality, containing pseudonyms ('AncientFang'), unverifiable claims ('most people have used my product'), and inaccurate audience definitions ('everyone'). The score reflects the high intrinsic value of the underlying business, heavily penalized by the poor response quality and the uncertainty introduced by the submitter's lack of professional detail.

Ready to Compete for $150k+ in Prizes?

Move this data into a HackerNoon blog draft to become eligible for your share of $150k+ in cash and software prizes

View All Reports

Score Breakdown

Real World Utility+22.50
Audience Reach Impact+9.60
Technical Innovation+12.00
Evidence Of Traction+15.75
Market Timing Relevance+8.50
Functional Completeness+0.25
Subtotal686.00)
Usefulness Multiplierx0.85
Final Score+583

Project Details

Description
Part of MLM Medical Labs since 01 June 2025. Cytespace labs has participated clinical trials in the clinical research industry since 1999. The laboratory is a fully CAP accredited facility which is based in Pretoria, South Africa. Supporting a wide spectrum of clients including biopharmaceutical, medical device and diagnostics customers. This full-service BSL3 laboratory includes capabilities spanning across the following services: - Project Management (Study startup and setup) - Pre-analytical (Sample accessioning) - Analytical (Safety and Esoteric) - Specimen Management and Storage (Ambient and Frozen) - Clinic supplies (Kit building) - Regulatory (Export / Import license) and Logistics Support TB key services; - Smear – conventional ZN and Fluorescent staining - Culture, Identification, and Susceptibility (1st and 2nd line) – BD - MGIT™ system as well as on LJ medium - HAINs assays – Genotypic drug resistance (GenoType® MTBDRplus/ - GenoType® MTBDR-sl ) and Speciation (GenoType® Mycobacterium CM/AS test) - GeneXpert® system - QuantiFERON® – TB Gold plus test - Advanced immunological assays, e.g., ELISPOT - MIC determination and New drug susceptibility We work with clients to specifically setup assays aligned to their specific clinical trial requirements and expected outcomes. Our Africa-Specific knowledge helps ensure your SAMPLES get to where they need to be ON TIME, and WITHIN TESTING PARAMETERS, which means you get the data you need WHEN YOU NEED IT. Contact us today and send us a request for information.

Algorithm Insights

Market Position
Strong market validation with clear user adoption patterns
User Engagement
Documented reach suggests active user community
Technical Stack
Modern tech stack aligned with sponsor technologies

Recommendations to Increase Usefulness Score

Document User Growth

Provide specific metrics on user acquisition and retention rates

Showcase Revenue Model

Detail sustainable monetization strategy and current revenue streams

Expand Evidence Base

Include testimonials, case studies, and third-party validation

Technical Roadmap

Share development milestones and feature completion timeline